Kinnate Biopharma Q2 EPS $(0.68) Down From $(0.62) YoY
Portfolio Pulse from Benzinga Newsdesk
Kinnate Biopharma reported Q2 losses of $(0.68) per share, a 9.68% decrease from the same period last year when losses were $(0.62) per share.
August 08, 2023 | 9:52 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Kinnate Biopharma's Q2 losses per share increased by 9.68% YoY, which could negatively impact investor sentiment.
Kinnate Biopharma's increased losses YoY indicate a worsening financial situation, which could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100